Broader use for opioid-induced constipation treatment

on the 5 August 2015

Use of Relistor (methylnaltrexone bromide) is no longer restricted to patients with advanced illness receiving palliative care. The injectable peripheral opioid antagonist is now indicated in adults in general for the treatment of opioid-induced constipation when laxatives are insufficient.

 


Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.